Mid-term efficacy & safety of CDA vs ACDF for 1-level cervical disc spondylosis
Effectiveness and safety of Mobi-C for treatment of single-level cervical disc spondylosis: a randomised control trial with a minimum of five years of follow-upBone Joint J. 2016 Jun;98-B(6):829-33
Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
107 patients with single-level cervical spondylosis were randomized to undergo either cervical disc arthroplasty (CDA) with the Mobi-C Cervical Disc Prosthesis or ACDF. The purpose of this study was to compare patient-reported outcome measures, the radiographic range of motion of the index segment, and subsequent surgery rates between groups. At 5 year follow-up, no significant differences were ob...
Learn about our AI Driven
High Impact Search Feature
The OE High Impact metric uses AI to determine the impact a study will have by considering the content of the article itself. Built using the latest advances of natural language processing techniques. OE High Impact predicts an article’s future number of citations than impact factor alone.Continue